Literature DB >> 32766671

Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19.

Paraskevi Theocharis1, James Wong1, Kuberan Pushparajah1,2, Sujeev K Mathur1, John M Simpson1, Emma Pascall1, Aoife Cleary1, Kirsty Stewart1, Kaitav Adhvaryu1, Alex Savis1, Saleha R Kabir1, Mirasol Pernia Uy1, Hannah Heard1, Kelly Peacock1, Owen Miller1,3.   

Abstract

AIMS: Following the peak of the UK COVID-19 epidemic, a new multisystem inflammatory condition with significant cardiovascular effects emerged in young people. We utilized multimodality imaging to provide a detailed sequential description of the cardiac involvement. METHODS AND
RESULTS: Twenty consecutive patients (mean age 10.6 ± 3.8 years) presenting to our institution underwent serial echocardiographic evaluation on admission (median day 5 of illness), the day coinciding with worst cardiac function (median day 7), and the day of discharge (median day 15). We performed cardiac computed tomography (CT) to assess coronary anatomy (median day 15) and cardiac magnetic resonance imaging (CMR) to assess dysfunction (median day 20). On admission, almost all patients displayed abnormal strain and tissue Doppler indices. Three-dimensional (3D) echocardiographic ejection fraction (EF) was <55% in half of the patients. Valvular regurgitation (75%) and small pericardial effusions (10%) were detected. Serial echocardiography demonstrated that the mean 3D EF deteriorated (54.7 ± 8.3% vs. 46.4 ± 8.6%, P = 0.017) before improving at discharge (P = 0.008). Left main coronary artery (LMCA) dimensions were significantly larger at discharge than at admission (Z score -0.11 ± 0.87 vs. 0.78 ± 1.23, P = 0.007). CT showed uniform coronary artery dilatation commonly affecting the LMCA (9/12). CMR detected abnormal strain in all patients with global dysfunction (EF <55%) in 35%, myocardial oedema in 50%, and subendocardial infarct in 5% (1/20) patients.
CONCLUSIONS: Pancarditis with cardiac dysfunction is common and associated with myocardial oedema. Patients require close monitoring due to coronary artery dilatation and the risk of thrombotic myocardial infarction. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; Hyper-inflammatory syndrome; Kawasaki; MIS-C; PIMS-TS; SARS-CoV-2

Mesh:

Year:  2021        PMID: 32766671      PMCID: PMC7454452          DOI: 10.1093/ehjci/jeaa212

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  46 in total

1.  The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives.

Authors:  Dongngan T Truong; Felicia L Trachtenberg; Gail D Pearson; Audrey Dionne; Matthew D Elias; Kevin Friedman; Kerri H Hayes; Lynn Mahony; Brian W McCrindle; Matthew E Oster; Victoria Pemberton; Andrew J Powell; Mark W Russell; Lara S Shekerdemian; Mary Beth Son; Michael Taylor; Jane W Newburger
Journal:  Am Heart J       Date:  2021-08-19       Impact factor: 4.749

2.  Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms.

Authors:  Laura Gellis; Daniel A Castellanos; Rebecca Oduor; Kimberlee Gauvreau; Audrey Dionne; Jane Newburger; Kevin G Friedman
Journal:  J Cardiovasc Comput Tomogr       Date:  2021-09-16

3.  Changes in the cardiovascular system in children with pediatric multisystem inflammatory syndrome temporally associated with COVID-19 - A single center experience.

Authors:  Aleksandra Stasiak; Piotr Kędziora; Beata Kierzkowska; Katarzyna Niewiadomska-Jarosik; Ewelina Perdas; Elżbieta Smolewska
Journal:  Int J Cardiol       Date:  2022-05-14       Impact factor: 4.039

4.  Advanced Echocardiographic Analysis in Medium-Term Follow-Up of Children with Previous Multisystem Inflammatory Syndrome.

Authors:  Massimo Garbin; Irene Raso; Alessandra Piersanti; Laura Gianolio; Annalisa De Silvestri; Valeria Calcaterra; Carla G Corti; Luisa F Nespoli; Sara Santacesaria; Giulia Fini; Dario Dilillo; Gianvincenzo Zuccotti; Savina Mannarino
Journal:  Children (Basel)       Date:  2022-06-18

5.  SARS-CoV-2 Associated Pediatric Inflammatory Multisystem Syndrome With a High Prevalence of Myocarditis - A Multicenter Evaluation of Clinical and Laboratory Characteristics, Treatment and Outcome.

Authors:  Katharina Thom; Beatrice Kahl; Thomas Wagner; Andreas van Egmond-Fröhlich; Mathias Krainz; Thomas Frischer; Iris Leeb; Christine Schuster; Doris Ehringer-Schetitska; Milen Minkov; Christoph Male; Ina Michel-Behnke
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

6.  A Mysterious Fever and Retropharyngeal Edema on a Previously Healthy 10-Year-Old Boy Without Known Exposure to COVID-19.

Authors:  Chenxuan Zhou; Mengyao Cheng; Hanyang Hong
Journal:  Cureus       Date:  2022-05-26

7.  Multisystemic inflammatory syndrome in children associated with COVID-19: a single center experience in Turkey.

Authors:  Eviç Zeynep Başar; Hafize Emine Sönmez; Selim Öncel; Ayşe Filiz Yetimakman; Kadir Babaoğlu
Journal:  Turk Arch Pediatr       Date:  2021-05-01

8.  Cardiac involvement in a child post COVID-19: a case from Lebanon.

Authors:  Tania H Abi Nassif; Karim N Daou; Theresia Tannoury; Marianne Majdalani
Journal:  BMJ Case Rep       Date:  2021-06-29

9.  Longitudinal Assessment of Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children Associated With COVID-19 Infections.

Authors:  Daisuke Matsubara; Joyce Chang; Hunter L Kauffman; Yan Wang; Sumekala Nadaraj; Chandni Patel; Stephen M Paridon; Mark A Fogel; Michael D Quartermain; Anirban Banerjee
Journal:  J Am Heart Assoc       Date:  2022-01-19       Impact factor: 6.106

10.  SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.

Authors:  Haldun Bulut; Alexandra H E Herbers; Ilse M G Hageman; Paetrick M Netten; Hendrik J M de Jonge; Robert Joustra; Frank L van de Veerdonk; Cornelis P C de Jager
Journal:  SN Compr Clin Med       Date:  2021-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.